======= USP21 =======
== Gene Information ==
* **Official Symbol**: USP21
* **Official Name**: ubiquitin specific peptidase 21
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=27005|27005]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9UK80|Q9UK80]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=USP21&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20USP21|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/604729|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Deubiquitinates histone H2A, a specific tag for epigenetic transcriptional repression, thereby acting as a coactivator. Deubiquitination of histone H2A releaves the repression of di- and trimethylation of histone H3 at 'Lys-4', resulting in regulation of transcriptional initiation. Regulates gene expression via histone H2A deubiquitination (By similarity). Also capable of removing NEDD8 from NEDD8 conjugates but has no effect on Sentrin-1 conjugates (PubMed:10799498). Deubiquitinates BAZ2A/TIP5 leading to its stabilization (PubMed:26100909). {ECO:0000250|UniProtKB:Q9QZL6, ECO:0000269|PubMed:10799498, ECO:0000269|PubMed:26100909}.
|UCH|
|NEDD8-specific protease activity|
|histone deubiquitination|
|cysteine-type peptidase activity|
|thiol-dependent ubiquitinyl hydrolase activity|
|thiol-dependent ubiquitin-specific protease activity|
|protein deubiquitination|
|transcription coactivator activity|
|protein modification by small protein removal|
|histone modification|
|covalent chromatin modification|
|ubiquitin-dependent protein catabolic process|
|modification-dependent protein catabolic process|
|modification-dependent macromolecule catabolic process|
|proteolysis involved in cellular protein catabolic process|
|cellular protein catabolic process|
|neuron projection development|
|protein catabolic process|
|chromatin organization|
|neuron development|
|cellular macromolecule catabolic process|
|protein modification by small protein conjugation or removal|
|neuron differentiation|
|macromolecule catabolic process|
|organonitrogen compound catabolic process|
|chromosome organization|
|plasma membrane bounded cell projection organization|
|cell projection organization|
|proteolysis|
|generation of neurons|
|positive regulation of transcription, DNA-templated|
|neurogenesis|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|cell development|
|positive regulation of RNA metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp108|Vinblastine 0.2μM R03 exp108]]|-1.79|
|[[:results:exp341|BRD2 inhibitor II 20μM R07 exp341]]|1.75|
|[[:results:exp389|PF-06409577 20μM R07 exp389]]|1.91|
|[[:results:exp391|Pomalidomide 20μM R07 exp391]]|1.93|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 1/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|1/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 15351
* **Expression level (log2 read counts)**: 5.06
{{:chemogenomics:nalm6 dist.png?nolink |}}